Investigators pooled 23 randomized controlled trials enrolling 3055 women with gestational diabetes mellitus to estimate effects of remote care on metabolic outcomes. The meta-analysis found statistically significant mean differences favoring telemedicine for fasting glucose (MD −0.26) and 2-hour postprandial glucose (MD −0.50). The study team also reported a modest reduction in gestational weight gain (MD −0.78). These pooled numbers were calculated across trials with varying telemedicine formats and follow-up schedules; the abstract did not provide detailed trial-by-trial intervention components in this summary.
The authors used Stata 18.0 for meta-analysis and applied 95% prediction intervals (PIs) for heterogeneous outcomes to estimate the range of effects likely in new studies. For fasting glucose, 2-hour postprandial glucose, and gestational weight gain, 95% PIs crossed the null despite statistically significant pooled means, indicating that future trials might show no effect or an effect in the opposite direction.
The GRADE appraisal produced low to very low certainty across outcomes. The review authors explicitly noted that the apparent improvements in glycemic control and weight should be considered tentative because of extreme between-study inconsistency and imprecision signaled by prediction intervals.
Pooled estimates suggested lower risks of several perinatal endpoints in telemedicine arms. The analysis reported reduced risks of cesarean section and emergency cesarean section, along with lower rates of macrosomia, neonatal hypoglycemia, and neonatal respiratory distress in the telemedicine groups. Conversely, the authors found no statistically significant pooled differences for hemoglobin A1c, preterm birth, or neonatal intensive care unit admission.
The abstract does not list absolute event counts, risk ratios, or confidence interval bounds for each perinatal outcome in this summary, so the magnitude of these risk reductions cannot be further detailed here without consulting the full paper. The study team advised caution interpreting these signals due to limitations in study consistency and reporting.
Several key outcomes exhibited very high heterogeneity, with I2 values greater than 90% for fasting glucose, 2-hour postprandial glucose, and gestational weight gain. The review authors conducted sensitivity analyses — including leave-one-out approaches, meta-regression, and subgroup analyses — to explore heterogeneity, though the abstract indicates much of that inconsistency remained unexplained.
By calculating 95% prediction intervals, the investigators illustrated that observed pooled effects may not reliably predict results of future trials; these intervals spanned the null for the most heterogeneous outcomes, reducing confidence in consistency and generalizability. The GRADE framework then downgraded evidence certainty accordingly, yielding overall ratings from very low to low.
The authors performed comprehensive searches in PubMed, Embase, Cochrane Library, Web of Science, and Scopus through August 16, 2026. Two reviewers independently completed study screening and data extraction. Risk of bias for included randomized trials was assessed with RoB 2. Publication bias was planned to be evaluated for outcomes reported in ten or more studies. For outcomes showing heterogeneity, the team reported both pooled estimates and 95% PIs to describe potential variability in future studies.
The abstract states these methods but does not provide a trial-by-trial risk-of-bias table or specifics on individual telemedicine modalities within this summary. Such granular information would be available in the full text.
The authors emphasized several constraints: extreme, unexplained between-study heterogeneity for primary metabolic outcomes; 95% prediction intervals crossing the null for those outcomes despite significant pooled results; and overall low to very low GRADE certainty. They explicitly stated that current evidence does not support replacing standard antenatal care with remote-only models for women with GDM.
To address evidence gaps, the study team recommended future, well-designed large RCTs that adopt standardized definitions for telemedicine interventions, fully report the components and intensity of remote care, and include long-term follow-up to verify sustained maternal and neonatal benefits. The abstract did not specify timelines, sample-size thresholds, or particular telemedicine technologies to prioritize; those operational details were not reported in the abstract.
These limitations end the report in concrete terms and point to specific, documentable next steps for trial design and reporting standards rather than broad, philosophical conclusions.